Clinical Significance of Electronegative Low-Density Lipoprotein Cholesterol in Atherothrombosis

Clinical Significance of Electronegative Low-Density Lipoprotein Cholesterol in Atherothrombosis

Despite the numerous risk factors for atherosclerotic cardiovascular diseases (ASCVD), cumulative evidence shows that electronegative low-density lipoprotein (L5 LDL) cholesterol is a promising biomarker. Its toxicity may contribute to atherothrombotic events. Notably, plasma L5 LDL levels positivel...

Full description

Bibliographic Details
Main Authors:	Chih-Sheng Chu, Shi Hui Law, David Lenzen, Yong-Hong Tan, Shih-Feng Weng, Etsuro Ito, Jung-Chou Wu, Chu-Huang Chen, Hua-Chen Chan, Liang-Yin Ke
Format:	Article
Language:	English
Published:	MDPI AG 2020-07-01
Series:	Biomedicines
Subjects:	electronegative low-density lipoprotein LDL(–) L5 LDL oxidized LDL oxLDL cardiovascular disease
Online Access:	https://www.mdpi.com/2227-9059/8/8/254

Similar Items

Molecular and Cellular Mechanisms of Electronegative Lipoproteins in Cardiovascular Diseases
by: Liang-Yin Ke, et al.
Published: (2020-11-01)

Electronegative LDL Is Associated with Plaque Vulnerability in Patients with Ischemic Stroke and Carotid Atherosclerosis
by: Núria Puig, et al.
Published: (2023-02-01)

The Influence of a Conjugated Pneumococcal Vaccination on Plasma Antibody Levels against Oxidized Low-Density Lipoprotein in Metabolic Disease Patients: A Single-Arm Pilot Clinical Trial
by: Ronit Shiri-Sverdlov, et al.
Published: (2021-01-01)

The Initial Human Atherosclerotic Lesion and Lipoprotein Modification—A Deep Connection
by: Michael Torzewski
Published: (2021-10-01)

Can Electronegative LDL Act as a Multienzymatic Complex?
by: Sonia Benitez, et al.
Published: (2023-04-01)

The Oxidized Lipoproteins In Vivo: Its Diversity and Behavior in the Human Circulation
by: Hiroyuki Itabe, et al.
Published: (2023-03-01)

Presence of Ceramidase Activity in Electronegative LDL
by: Núria Puig, et al.
Published: (2022-12-01)

Efficacy of Hydroxytyrosol-Rich Food Supplements on Reducing Lipid Oxidation in Humans
by: Cecilia Bender, et al.
Published: (2023-03-01)

Homeopathic preparation of Allium sativum abrogates OxLDL mediated atherogenic events in macrophages: An in vitro and in silico approach
by: Thangarajeswari Mohan, et al.
Published: (2024-01-01)

Effects of curcumin on low-density lipoprotein oxidation
by: Fatemeh Baratzadeh, et al.
Published: (2022-06-01)

High-Density Lipoprotein Suppresses Neutrophil Extracellular Traps Enhanced by Oxidized Low-Density Lipoprotein or Oxidized Phospholipids
by: Hitomi Ohinata, et al.
Published: (2022-11-01)

Effect of Oxidized Low-Density Lipoprotein on Head and Neck Squamous Cell Carcinomas
by: Nadège Kindt, et al.
Published: (2021-05-01)

Antioxidant Efficacy of a <i>Spirulina</i> Liquid Extract on Oxidative Stress Status and Metabolic Disturbances in Subjects with Metabolic Syndrome
by: N’Deye Lallah Nina Koite, et al.
Published: (2022-07-01)

Oxidized LDL Modifies the Association between Proteinuria and Deterioration of Kidney Function in Proteinuric Diabetic Kidney Disease
by: Stefanos Roumeliotis, et al.
Published: (2021-05-01)

TGF-β Isoforms and GDF-15 in the Development and Progression of Atherosclerosis
by: Agnė Liuizė (Abramavičiūtė), et al.
Published: (2024-02-01)

LXRα Regulates oxLDL-Induced Trained Immunity in Macrophages
by: Hannes M. Findeisen, et al.
Published: (2022-05-01)

PACAP regulates VPAC1 expression, inflammatory processes and lipid homeostasis in M1- and M2-macrophages
by: Roman Witzel, et al.
Published: (2023-10-01)

Exposure to oxLDL impairs TGF-β activity in human tendon cells
by: Rouhollah Mousavizadeh, et al.
Published: (2023-03-01)

P62 Links the Autophagy Pathway and the Ubiquitin–Proteasome System in Endothelial Cells during Atherosclerosis
by: SeJeong Kim, et al.
Published: (2021-07-01)

Hydroxytyrosol Reduces Foam Cell Formation and Endothelial Inflammation Regulating the PPARγ/LXRα/ABCA1 Pathway
by: Sara Franceschelli, et al.
Published: (2023-01-01)

GRP78/BiP alleviates oxLDL-induced hepatotoxicity in familial hypercholesterolemia caused by missense variants of LDLR in a HepG2 cellular model
by: Divya Saro Varghese, et al.
Published: (2023-05-01)

A Novel Immunoassay for Malondialdehyde-Conjugated Low-Density Lipoprotein Measures Dynamic Changes in the Blood of Patients Undergoing Coronary Artery Bypass Graft Surgery
by: Samata S. Pandey, et al.
Published: (2021-08-01)

Depletion of Homeostatic Antibodies against Malondialdehyde-Modified Low-Density Lipoprotein Correlates with Adverse Events in Major Vascular Surgery
by: Adam Hartley, et al.
Published: (2022-01-01)

Lipids and lipoproteins may play a role in the neuropathology of Alzheimer’s disease
by: Omer Akyol, et al.
Published: (2023-11-01)

Contribution of adipocyte Na/K-ATPase α1/CD36 signaling induced exosome secretion in response to oxidized LDL
by: Sneha S. Pillai, et al.
Published: (2023-04-01)

Why Some Patients Undergoing Lipoprotein Apheresis Therapy Develop New Cardiovascular Events?
by: Ulrich Julius, et al.
Published: (2020-07-01)

Impact of Glucagon-Like Peptide 1 Receptor Agonists on Biochemical Markers of the Initiation of Atherosclerotic Process
by: Marcin Hachuła, et al.
Published: (2024-02-01)

The Interplay between Atherosclerosis and Cancer: Breast Cancer Cells Increase the Expression of Endothelial Cell Adhesion Markers
by: Alessandro Scalia, et al.
Published: (2023-06-01)

The Effect of a 13-Valent Conjugate Pneumococcal Vaccine on Circulating Antibodies Against Oxidized LDL and Phosphorylcholine in Man, A Randomized Placebo-Controlled Clinical Trial
by: Hendrika W. Grievink, et al.
Published: (2020-10-01)

Development of a Method for Producing oxLDL: Characterization of Their Effects on HPV-Positive Head and Neck Cancer Cells
by: Alessandro Scalia, et al.
Published: (2022-10-01)

Paradoxical mortality differential of HDL cholesterol
by: Jyotishman Mukhopadhyay, et al.
Published: (2023-05-01)

Transfer and Enzyme-Mediated Metabolism of Oxidized Phosphatidylcholine and Lysophosphatidylcholine between Low- and High-Density Lipoproteins
by: Naoko Sawada, et al.
Published: (2020-10-01)

Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk
by: Hidekatsu Yanai, et al.
Published: (2022-11-01)

Oxidised LDL and Anti-Oxidised LDL Antibodies Are Reduced by Lipoprotein Apheresis in a Randomised Controlled Trial on Patients with Refractory Angina and Elevated Lipoprotein(a)
by: Tina Z. Khan, et al.
Published: (2021-01-01)

Glycation of LDL: AGEs, impact on lipoprotein function, and involvement in atherosclerosis
by: Anastasia V. Poznyak, et al.
Published: (2023-01-01)

Relationship between Lipoprotein(a) and Dyslipidemia in the Elderly over 60 Years
by: Yo-Han Seo, et al.
Published: (2022-06-01)

Aggregation Susceptibility of Low-Density Lipoproteins—A Novel Modifiable Biomarker of Cardiovascular Risk
by: Katariina Öörni, et al.
Published: (2021-04-01)

Novel Tools for Comprehensive Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants
by: Jacek Jasiecki, et al.
Published: (2023-07-01)

The Significance of Lipoproteins in the Development of Obesity
by: Alexander Blagov, et al.
Published: (2024-03-01)

Association of LDL-cholesterol subfractions with cardiovascular disorders: a systematic review
by: Abdolreza Chary, et al.
Published: (2023-11-01)